Covariate | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
T stage | ||||
T2 | 2.89 (1.030–8.106) | 0.044 | 1.645 (0.548–4.935) | 0.374 |
T3 | 11.638 (3.801–35.633) | < 0.001 | 2.658 (0.551–12.819) | 0.223 |
N stage | ||||
N1 | 1.716 (0.639–4.608) | 0.284 | 1.267 (0.413–3.889) | 0.679 |
N2 | 4.938 (1.521–16.037) | 0.008 | 1.749 (0.318–9.631) | 0.521 |
N3 | 12.961 (4.582–36.666) | < 0.001 | 5.347 (1.162–24.603) | 0.031 |
ER | 0.206 (0.093–0.453) | < 0.001 | 0.873 (0.228–3.348) | 0.843 |
PR | 0.212 (0.092–0.487) | < 0.001 | 0.783 (0.194–3.163) | 0.731 |
HER2 | 2.592 (1.190–5.643) | 0.016 | 2.843 (0.743–10.872) | 0.127 |
TNBC | 2.963 (1.245–7.052) | 0.014 | 4.505 (0.801–25.329) | 0.088 |
Breast-conserving surgery | 0.224 (0.102–0.495) | < 0.001 | 0.502 (0.187–1.352) | 0.173 |
SUVRmean | 3.633 (1.668–7.911) | 0.001 | 2.007 (0.755–5.335) | 0.163 |
SUVRmax | 4.987 (2.167–11.475) | < 0.001 | 3.014 (1.002–9.071) | 0.050 |